BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7719906)

  • 21. The immunogenicity of the liposome-associated outer membrane proteins (OMPs) of Moraxella catarrhalis.
    Augustyniak D; Mleczko J; Gutowicz J
    Cell Mol Biol Lett; 2010; 15(1):70-89. PubMed ID: 19851720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies.
    Helminen ME; Maciver I; Latimer JL; Klesney-Tait J; Cope LD; Paris M; McCracken GH; Hansen EJ
    J Infect Dis; 1994 Oct; 170(4):867-72. PubMed ID: 7523537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies specific to outer membrane antigens of Moraxella catarrhalis in sera and middle ear effusions from children with otitis media with effusion.
    Takada R; Harabuchi Y; Himi T; Kataura A
    Int J Pediatr Otorhinolaryngol; 1998 Dec; 46(3):185-95. PubMed ID: 10190589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
    Hoban DJ; Zhanel GG; Karlowsky JA
    Diagn Microbiol Infect Dis; 1999 Sep; 35(1):37-44. PubMed ID: 10529880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.
    Murphy TF
    Microbiol Rev; 1996 Jun; 60(2):267-79. PubMed ID: 8801433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis.
    Burman LA; Leinonen M; Trollfors B
    J Infect Dis; 1994 Jul; 170(1):220-2. PubMed ID: 8014504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence of respiratory tract pathogens and antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated between 1990 and 1993.
    Nishioka K; Ogihara H; Ohno I; Tanno Y; Shirato K
    Tohoku J Exp Med; 1996 Jun; 179(2):111-21. PubMed ID: 8875767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life.
    Borges IC; Andrade DC; Cardoso MR; Toppari J; Vähä-Mäkilä M; Ilonen J; Knip M; Hyöty H; Veijola R; Simell O; Jartti T; Käyhty H; Ruuskanen O; Nascimento-Carvalho CM
    Clin Vaccine Immunol; 2016 Nov; 23(11):878-883. PubMed ID: 27581439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.
    Adlowitz DG; Sethi S; Cullen P; Adler B; Murphy TF
    Infect Immun; 2005 Oct; 73(10):6601-7. PubMed ID: 16177336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease.
    Adlowitz DG; Kirkham C; Sethi S; Murphy TF
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):139-46. PubMed ID: 16420607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Moraxella catarrhalis outer membrane antigens cross-reactive with Neisseria meningitidis and Neisseria lactamica.
    Troncoso G; Sánchez S; Criado MT; Ferreirós C
    FEMS Immunol Med Microbiol; 2004 Jan; 40(1):89-94. PubMed ID: 14734192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants.
    Verhaegh SJ; de Vogel CP; Riesbeck K; Lafontaine ER; Murphy TF; Verbrugh HA; Jaddoe VW; Hofman A; Moll HA; van Belkum A; Hays JP
    Vaccine; 2011 Aug; 29(34):5603-10. PubMed ID: 21704103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model.
    Murphy TF; Kyd JM; John A; Kirkham C; Cripps AW
    J Infect Dis; 1998 Dec; 178(6):1667-75. PubMed ID: 9815219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
    Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents.
    Blondeau JM; Vaughan D; Laskowski R; Borsos S;
    Int J Antimicrob Agents; 2001 Jun; 17(6):457-64. PubMed ID: 11397615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media.
    Mathers K; Leinonen M; Goldblatt D
    Pediatr Infect Dis J; 1999 Nov; 18(11):982-8. PubMed ID: 10571435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain.
    Escribano Montaner A; García de Lomas J; Villa Asensi JR; Asensio de la Cruz O; de la Serna Blázquez O; Santiago Burruchaga M; Mondéjar López P; Torrent Vernetta A; Feng Y; Van Dyke MK; Reyes J; Garcia-Corbeira P; Talarico CA;
    Eur J Pediatr; 2018 Feb; 177(2):181-192. PubMed ID: 29285648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children.
    Xu Q; Pichichero ME
    Vaccine; 2014 Feb; 32(6):706-11. PubMed ID: 24355091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection.
    Rahman M; Holme T; Jönsson I; Krook A
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):297-304. PubMed ID: 7649192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.
    Helminen ME; Maciver I; Latimer JL; Cope LD; McCracken GH; Hansen EJ
    Infect Immun; 1993 May; 61(5):2003-10. PubMed ID: 7683000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.